Reporting guideline provided for? (i.e. exactly what the authors state in the paper)
Reporting of early phase (phase I and non-randomised phase II) clinical trial statistical analysis plans (SAPs).
Full bibliographic reference
Homer V, Yap C, Bond S, Holmes J, Stocken D, Walker K, Robinson EJ, Wheeler G, Brown S, Hinsley S, Schipper M, Weir CJ, Rantell K, Prior T, Yu LM, Kirkpatrick J, Bedding A, Gamble C, Gaunt P. Early phase clinical trials extension to guidelines for the content of statistical analysis plans. BMJ. 2022;376:e068177.
Language
English
PubMed ID
Relevant URLs (full-text if available)
Read the full-text of this reporting guideline for early phase clinical trial statistical analysis plans.
Relevant more generic / specialised reporting guidelines (i.e. main generic guideline or extension to a generic guideline)
Generic
Clinical Trial Statistical Analysis Plans: Gamble C, Krishan A, Stocken D, Lewis S, Juszczak E, Doré C, Williamson PR, Altman DG, Montgomery A, Lim P, Berlin J, Senn S, Day S, Barbachano Y, Loder E. Guidelines for the Content of Statistical Analysis Plans in Clinical Trials. JAMA. 2017;318(23):2337-2343. PMID: 29260229
Study design
Clinical trials, Experimental studies
Applies to the whole report or to individual sections of the report?
Statistical analysis plan-whole report
Record last updated on
February 14, 2022
Training
The UK EQUATOR Centre runs training on how to write using reporting guidelines.